Duggirala NK - Search Results

1

Improving lithium therapeutics by crystal engineering of novel ionic cocrystals.

Smith AJ, Kim SH, Duggirala NK, Jin J, Wojtas L, Ehrhart J, Giunta B, Tan J, Zaworotko MJ, Shytle RD. Smith AJ, et al. Among authors: duggirala nk. Mol Pharm. 2013 Dec 2;10(12):4728-38. doi: 10.1021/mp400571a. Epub 2013 Nov 18. Mol Pharm. 2013. PMID: 24191685 Free PMC article.

2

Solid-State Characterization and Relative Formation Enthalpies To Evaluate Stability of Cocrystals of an Antidiabetic Drug.

Duggirala NK, Frericks Schmidt HL, Lei Z, Zaworotko MJ, Krzyzaniak JF, Arora KK. Duggirala NK, et al. Mol Pharm. 2018 May 7;15(5):1901-1908. doi: 10.1021/acs.molpharmaceut.8b00061. Epub 2018 Apr 24. Mol Pharm. 2018. PMID: 29659293

3

Pharmaceutical cocrystals: along the path to improved medicines.

Duggirala NK, Perry ML, Almarsson Ö, Zaworotko MJ. Duggirala NK, et al. Chem Commun (Camb). 2016 Jan 14;52(4):640-55. doi: 10.1039/c5cc08216a. Chem Commun (Camb). 2016. PMID: 26565650

4

Formation of Indomethacin-Saccharin Cocrystals during Wet Granulation: Role of Polymeric Excipients.

Tanaka R, Duggirala NK, Hattori Y, Otsuka M, Suryanarayanan R. Tanaka R, et al. Among authors: duggirala nk. Mol Pharm. 2020 Jan 6;17(1):274-283. doi: 10.1021/acs.molpharmaceut.9b01004. Epub 2019 Dec 18. Mol Pharm. 2020. PMID: 31756100

5

Role of Lattice Disorder in Water-Mediated Dissociation of Pharmaceutical Cocrystal Systems.

Kaur N, Duggirala NK, Thakral S, Suryanarayanan R. Kaur N, et al. Among authors: duggirala nk. Mol Pharm. 2019 Jul 1;16(7):3167-3177. doi: 10.1021/acs.molpharmaceut.9b00386. Epub 2019 Jun 4. Mol Pharm. 2019. PMID: 31117742

6

Design of Ternary Amorphous Solid Dispersions for Enhanced Dissolution of Drug Combinations.

Li J, Duggirala NK, Kumar NSK, Su Y, Suryanarayanan R. Li J, et al. Among authors: duggirala nk. Mol Pharm. 2022 Aug 1;19(8):2950-2961. doi: 10.1021/acs.molpharmaceut.2c00307. Epub 2022 Jul 7. Mol Pharm. 2022. PMID: 35797094

7

Dual Functionality of Bile Acid: Physical Stabilization of Drugs in the Amorphous Form and Solubility Enhancement in Solution.

Lalge R, Kaur N, Duggirala NK, Suryanarayanan R. Lalge R, et al. Among authors: duggirala nk. Mol Pharm. 2022 Jul 4;19(7):2595-2606. doi: 10.1021/acs.molpharmaceut.2c00294. Epub 2022 Jun 10. Mol Pharm. 2022. PMID: 35687125

8

Mechanistic Insight into Caffeine-Oxalic Cocrystal Dissociation in Formulations: Role of Excipients.

Duggirala NK, Vyas A, Krzyzaniak JF, Arora KK, Suryanarayanan R. Duggirala NK, et al. Mol Pharm. 2017 Nov 6;14(11):3879-3887. doi: 10.1021/acs.molpharmaceut.7b00587. Epub 2017 Oct 9. Mol Pharm. 2017. PMID: 28990387

9

Phase behavior of poloxamer 188 in frozen aqueous solutions - Influence of processing conditions and cosolutes.

Duggirala NK, Sonje J, Yuan X, Shalaev E, Suryanarayanan R. Duggirala NK, et al. Int J Pharm. 2021 Nov 20;609:121145. doi: 10.1016/j.ijpharm.2021.121145. Epub 2021 Sep 29. Int J Pharm. 2021. PMID: 34600056

10

A supramolecular synthon approach to design amorphous solid dispersions with exceptional physical stability.

Duggirala NK , Li J , Kumar NSK , Gopinath T , Suryanarayanan R . Duggirala NK , et al. Chem Commun (Camb). 2019 May 9;55(39):5551-5554. doi: 10.1039/c9cc02021g. Chem Commun (Camb). 2019. PMID: 30972394

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters